Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/175294Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Esteve Pitarch, Erika | - |
| dc.contributor.author | Padullés Zamora, Ariadna | - |
| dc.contributor.author | Maisterra-Santos, Kristel | - |
| dc.contributor.author | Colom Codina, Helena | - |
| dc.contributor.author | Cobo Sacristán, Sara | - |
| dc.date.accessioned | 2021-03-18T09:33:27Z | - |
| dc.date.available | 2021-03-18T09:33:27Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.issn | 0210-6329 | - |
| dc.identifier.uri | http://hdl.handle.net/2445/175294 | - |
| dc.description.abstract | Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem. | - |
| dc.format.extent | 7 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | Sociedad Española de Farmacia Hospitalaria | - |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.7399/fh.11170 | - |
| dc.relation.ispartof | Farmacia Hospitalaria, 2019 | - |
| dc.relation.uri | https://doi.org/10.7399/fh.11170 | - |
| dc.rights | cc by-nc-sa (c) Sociedad Española de Farmacia Hospitalaria, 2019 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/es/ | * |
| dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | - |
| dc.subject.classification | Antibiòtics betalactàmics | - |
| dc.subject.classification | Medicina intensiva | - |
| dc.subject.classification | Farmacocinètica | - |
| dc.subject.other | Beta lactam antibiotics | - |
| dc.subject.other | Critical care medicine | - |
| dc.subject.other | Pharmacokinetics | - |
| dc.title | OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.identifier.idgrec | 698394 | - |
| dc.date.updated | 2021-03-18T09:33:27Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 698394.pdf | 351.15 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
